Multiphasic construct studied in an ectopic osteochondral defect model.
In vivo osteochondral defect models predominantly consist of small animals, such as rabbits. Although they have an advantage of low cost and manageability, their joints are smaller and more easily healed compared with larger animals or humans. We hypothesized that osteochondral cores from large animals can be implanted subcutaneously in rats to create an ectopic osteochondral defect model for routine and high-throughput screening of multiphasic scaffold designs and/or tissue-engineered constructs (TECs). Bovine osteochondral plugs with 4 mm diameter osteochondral defect were fitted with novel multiphasic osteochondral grafts composed of chondrocyte-seeded alginate gels and osteoblast-seeded polycaprolactone scaffolds, prior to being implanted in rats subcutaneously with bone morphogenic protein-7. After 12 weeks of in vivo implantation, histological and micro-computed tomography analyses demonstrated that TECs are susceptible to mineralization. Additionally, there was limited bone formation in the scaffold. These results suggest that the current model requires optimization to facilitate robust bone regeneration and vascular infiltration into the defect site. Taken together, this study provides a proof-of-concept for a high-throughput osteochondral defect model. With further optimization, the presented hybrid in vivo model may address the growing need for a cost-effective way to screen osteochondral repair strategies before moving to large animal preclinical trials.
Institute of Health and Biomedical Innovation, Queensland University of Technology, , 60 Musk Avenue, Kelvin Grove, Queensland 4059, Australia.
June E
JE
Jeon
Cédryck
C
Vaquette
Christina
C
Theodoropoulos
Travis J
TJ
Klein
Dietmar W
DW
Hutmacher
D000818:Animals; D001847:Bone Diseases / Q000473:pathology / Q000628:therapy; D001842:Bone and Bones / Q000293:injuries / Q000378:metabolism / Q000473:pathology; D002356:Cartilage / Q000293:injuries / Q000378:metabolism / Q000473:pathology; D002357:Cartilage Diseases / Q000473:pathology / Q000628:therapy; D002417:Cattle; D002478:Cells, Cultured; D019902:Chondrocytes / Q000378:metabolism / Q000473:pathology / Q000637:transplantation; D004195:Disease Models, Animal; D006801:Humans; D011091:Polyesters / Q000737:chemistry / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds
D011091:Polyesters; C016240:polycaprolactone
biomaterials; in vivo model; multiphasic scaffold; osteochondral repair; tissue engineering